• Mashup Score: 2

    During a Targeted Oncology case-based roundtable event, Nilofer S. Azad, MD, discussed the data supporting the previous standard of care and the new frontline regimen of gemcitabine, cisplatin, and durvalumab for patients with biliary tract cancers.

    Tweet Tweets with this article
    • Nilofer S. Azad, MD, discussed the previous standard of care vs new frontline regimen of gemcitabine, cisplatin, and durvalumab for patients with biliary tract cancers. #BTC #gicsm | @JohnsHopkins @hopkinskimmel https://t.co/KSLExKMbDN

  • Mashup Score: 0

    Donate to your Favorite Charity in Bitcoin and other Digital Assets with spare change roundups.

    Tweet Tweets with this article
    • With @RoundlyX + @TheGivingBlock, crypto holders can support our mission with roundup donations from everyday purchases. 🚀❤️ Learn more: https://t.co/EVHW49oSDr #CancerCryptoFund #btc #eth https://t.co/VXQnOiBsKq https://t.co/OiPVpYv2ik